Virtu Financial LLC - NABRIVA THERAPEUTICS PLC ownership

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 32 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2022$23,000
-30.3%
127,585
+60.4%
0.00%0.0%
Q1 2022$33,000
-73.6%
79,556
-62.0%
0.00%
-84.6%
Q4 2021$125,000
+145.1%
209,443
+452.4%
0.01%
+160.0%
Q2 2021$51,000
-1.9%
37,915
+21.6%
0.01%
+25.0%
Q1 2021$52,000
-1.9%
31,186
+41.4%
0.00%
-33.3%
Q4 2020$53,00022,0600.01%
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$317,0000.06%
FRAZIER MANAGEMENT LLC 425,650$707,0000.06%
Values First Advisors, Inc. 45,033$75,0000.06%
SABBY MANAGEMENT, LLC 164,007$272,0000.05%
ABG Innovation Capital Partners III GP Ltd 45,849$76,0000.04%
CCG WEALTH MANAGEMENT, LLC 10,480$17,0000.02%
Virtu Financial LLC 31,186$52,0000.00%
KESTRA PRIVATE WEALTH SERVICES, LLC 31,274$52,0000.00%
WINTON GROUP Ltd 33,211$55,0000.00%
Squarepoint Ops LLC 156,623$260,0000.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders